glp-1 receptor agonists in pediatric and adolescent obesity Updates on Anti-Obesity Medications Children Adolescents Science Behind GLP 1 GIP
Description
& Okovityi, S

Int Wound J (2013) 10:55561

D., Klammt, S., Posch, M

British journal of clinical pharmacology , 84 (10), 2325-2335

It Is Time to Reconsider the Cardiovascular Protection Afforded by RAAS Blockade Overview of RAAS Systems
